Citation Impact
Citing Papers
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
2009
Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors
2001
Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC–MS/MS method
2006
Disulfonimide‐Catalyzed Asymmetric Reduction of N‐Alkyl Imines
2015 StandoutNobel
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Combinatorial synthesis and biological evaluation of isoxazole-based libraries as antithrombotic agents
2002
The Pharmacogenetics of Immunosuppression for Organ Transplantation
2003
Piroxicam-??-Cyclodextrin
1994
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.
1995 Standout
Future trends in the development of safer nonsteroidal anti-inflammatory drugs
1998
Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective
1995
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
2011
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Paclitaxel (Taxol)
1995 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Timing of New Black Box Warnings and Withdrawals for Prescription Medications
2002 Standout
Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product
2022 Standout
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Catalytic Asymmetric Reductive Amination of α‐Branched Ketones
2010 StandoutNobel
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
2014 StandoutNobel
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
2013 Standout
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Clinical Pharmacokinetics of Ibuprofen
1998
Targeting multidrug resistance in cancer
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Inhibitors of Tubulin Assembly Identified through Screening a Compound Library
2008
Drug-induced heart failure
1999
Pharmacokinetic Optimisation of Antiemetic Therapy
1992
Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation
2005
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
2003 StandoutNobel
Thermodynamic analysis of water molecules at the surface of proteins and applications to binding site prediction and characterization
2011
Cyclo-Oxygenase Isoenzymes
1997
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Considerations in the design and development of transport inhibitors as adjuncts to drug therapy
2003
Myocarditis
2000 Standout
Intermolecular and Intramolecular Hydrogen Bonds Involving Fluorine Atoms: Implications for Recognition, Selectivity, and Chemical Properties
2012
The ChEMBL database in 2017
2016 Standout
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Synthetic glycopeptides and glycoproteins as tools for biology
2004 StandoutNobel
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Trifluoromethylation of Aromatic Isoxazoles: Regio‐ and Diastereoselective Route to 5‐Trifluoromethyl‐2‐isoxazolines
2011
Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances
2006
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Controlled Microwave Heating in Modern Organic Synthesis
2004 Standout
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Virtual Screening with Flexible Docking and COMBINE-Based Models. Application to a Series of Factor Xa Inhibitors
2004
Combining the use of solid‐supported transition metal catalysis with microwave irradiation in solution‐phase parallel library synthesis
2003
Two-Step Synthesis of Substituted 3-Aminoindazoles from 2-Bromobenzonitriles
2010
3d Transition Metals for C–H Activation
2018 Standout
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
Catalytic Asymmetric Reductive Condensation of N–H Imines: Synthesis of C2‐Symmetric Secondary Amines
2016 StandoutNobel
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Trifluoromethylation of Aromatic Isoxazoles: Regio‐ and Diastereoselective Route to 5‐Trifluoromethyl‐2‐isoxazolines
2011
Recent Advances in the Synthesis of Pyrazoles. A Review
2009
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
An Investigation of Thin-Film Ni–Fe Oxide Catalysts for the Electrochemical Evolution of Oxygen
2013 Standout
An Aminopyridinato Titanium Catalyst for the Intramolecular Hydroaminoalkylation of Secondary Aminoalkenes
2015
Catalytic Asymmetric Reductive Amination of α‐Branched Ketones
2010 StandoutNobel
Docking and scoring in virtual screening for drug discovery: methods and applications
2004 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Structural Requirements for Factor Xa Inhibition by 3-Oxybenzamides with Neutral P1 Substituents: Combining X-ray Crystallography, 3D-QSAR, and Tailored Scoring Functions
2005
Precise Modulation of CO2 Sorption in Ti8Ce2–Oxo Clusters: Elucidating Lewis Acidity of the Ce Metal Sites and Structural Flexibility
2024 StandoutNobel
Raman scattering in spinel structure ferrites
1988
Microwave‐Assisted Solution‐Phase Synthesis of 1,4,5‐Trisubstituted Pyrazoles
2003
The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.
1998
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits
2009
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa
2007
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
The Halogen Bond
2016 Standout
Complete Field Guide to Asymmetric BINOL-Phosphate Derived Brønsted Acid and Metal Catalysis: History and Classification by Mode of Activation; Brønsted Acidity, Hydrogen Bonding, Ion Pairing, and Metal Phosphates
2014 Standout
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Bisphenol-A and the Great Divide: A Review of Controversies in the Field of Endocrine Disruption
2009 Standout
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles
2011 Standout
Design, Structure−Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa Inhibitors
2008
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Enkephalin Glycopeptide Analogues Produce Analgesia with Reduced Dependence Liability
2000
Novel Small-Molecule Inhibitors of Anthrax Lethal Factor Identified by High-Throughput Screening
2006
Recent Advances in the Baylis−Hillman Reaction and Applications
2003 Standout
Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system.
1998
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and Analogues as A2A Adenosine Receptor Antagonists. Design, Synthesis, and Pharmacological Characterization
2005
Works of Matthew Wright being referenced
Possible Role of the Intestinal P‐450 Enzyme System in a Cyclosporine‐Clarithromycin Interaction
1996
SAR studies on a novel series of human cytomegalovirus primase inhibitors
2007
Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs
2008
Antiinflammatory Drug-Induced Small Intestinal Permeability: The Rat Is a Suitable Model
1994
Improved high-performance liquid chromatographic assay method for the enantiomers of ibuprofen
1992
Isoxazolines and isoxazoles as factor Xa inhibitors
2000
Differences in NSAID Tolerability Profiles
1994
Optimizing the use of cyclosporine in renal transplantation
1995
THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
2004
Nonpeptide Factor Xa Inhibitors III: Effects of DPC423, an Orally-Active Pyrazole Antithrombotic Agent, on Arterial Thrombosis in Rabbits
2002
Phase 2 study of T138067-sodium in patients with malignant glioma: Trialof the National Cancer Institute of Canada Clinical Trials Group
2005
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors
1998
Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2
1999
Effect of haemodialysis on metoclopramide kinetics in patients with severe renal failure.
1988
Effect of the Enantiomers of Flurbiprofen, Ibuprofen, and Ketoprofen on Intestinal Permeability
1996
Nonsymmetric P2/P2‘ Cyclic Urea HIV Protease Inhibitors. Structure−Activity Relationship, Bioavailability, and Resistance Profile of Monoindazole-Substituted P2 Analogues
1998
Clearance and disposition of ritodrine in the fluid compartments of the fetal lamb during and after constant rate fetal intravenous infusion.
1991
Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa
2001
Linearity of metoclopramide kinetics at doses of 5‐20 mg.
1988
Preclinical Evaluation of GS-9160, a Novel Inhibitor of Human Immunodeficiency Virus Type 1 Integrase
2008
Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants
2003
Nickel iron ferrite crystals using arc image furnace techniques
1967
Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor
2003
Hepatic metabolism and biliary excretion of Taxol in rats and humans.
1993